Millipore Sigma Vibrant Logo

239900 Cypermethrin - CAS 52315-07-8 - Calbiochem

Synthetic type II pyrethroid. Potent inhibitor of calcineurin (protein phosphatase 2B; IC₅₀ = 40 pM). May also have varied effects on ion channels.

Cypermethrin - CAS 52315-07-8 - Calbiochem: MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.

Sinonimi: (R,S)-α-Cyano-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate

Primary Target: calcineurin
View Products on Sigmaaldrich.com
239900
Visualizza prezzi e disponibilità

Panoramica

Replacement Information

Tabella delle specifiche principali

CAS #Empirical Formula
52315-07-8C₂₂H₁₉Cl₂NO₃

Prezzi e disponibilità

Numero di catalogo DisponibilitàConfezionamento Qtà/conf Prezzo Quantità
239900-10MG
Verifica della disponibilità in corso...
—
Disponibilità limitata Disponibilità limitata
A magazzino 
Fuori produzione
Disponibili quantità limitate
La disponibilità deve essere confermata
    Prodotti rimanenti: riceverà un nostro avviso
      Prodotti rimanenti: riceverà un nostro avviso
      Will advise
      Contatti il Servizio Clienti
      Contact Customer Service

      		 Fusto in alluminio 10 mg
      Ricerca del prezzo in corso...
      Non è stato possibile trovare il prezzo
      La quantità minima deve essere un multiplo di
      Maximum Quantity is
      Al termine dell'ordine Maggiori informazioni
      Lei ha salvato ()
       
      —
      Richiedi il prezzo
      		 —
      Description
      OverviewSynthetic type II pyrethroid. Potent inhibitor of calcineurin (protein phosphatase 2B; IC50 = 40 pM). May also have varied effects on ion channels.
      Catalogue Number239900
      Brand Family Calbiochem®
      Synonyms(R,S)-α-Cyano-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
      References
      ReferencesRichter, A., et al. 1995. Biochem. Pharmacol. 49, 367.
      Wang, J.H., and Stelzer, A. 1994. NeuroReport 5, 2377.
      Enan, E., and Matsumura, F. 1992. Biochem. Pharmacol. 43, 1777.
      Narahasi, T. 1992. Trends Pharmacol. Sci. 13, 236.
      Product Information
      CAS number52315-07-8
      ATP CompetitiveN
      FormOil
      Hill FormulaC₂₂H₁₉Cl₂NO₃
      Chemical formulaC₂₂H₁₉Cl₂NO₃
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary Targetcalcineurin
      Primary Target IC<sub>50</sub>40 pM against calcineurin (protein phosphatase 2B
      Purity≥95% by HPLC
      Physicochemical Information
      Cell permeableN
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSGZ1250000
      Safety Information
      R PhraseR: 25-36/38

      Toxic if swallowed.
      Irritating to eyes and skin.
      S PhraseS: 26-36/37/39-45

      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Wear suitable protective clothing, gloves and eye/face protection.
      In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Toxic
      Hazardous Materials Attention: Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
      Storage +2°C to +8°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Numero di catalogo GTIN
      239900-10MG 04055977199055

      Documentation

      Cypermethrin - CAS 52315-07-8 - Calbiochem MSDS

      Titolo

      Scheda di sicurezza (MSDS) 

      Cypermethrin - CAS 52315-07-8 - Calbiochem Certificati d'Analisi

      TitoloNumero di lotto
      239900

      Riferimenti bibliografici

      Panoramica delle referenze
      Richter, A., et al. 1995. Biochem. Pharmacol. 49, 367.
      Wang, J.H., and Stelzer, A. 1994. NeuroReport 5, 2377.
      Enan, E., and Matsumura, F. 1992. Biochem. Pharmacol. 43, 1777.
      Narahasi, T. 1992. Trends Pharmacol. Sci. 13, 236.

      Brochure

      Titolo
      Protein Phosphatases Technical Bulletin

      Citazioni

      Titolo
    • Mike T. Lin, et al. (2005) Ca2+-activated K+ channel-associated phosphatase and kinase activities during development. American Journal of Physiology Heart and Circulatory Physiology 289, H414-H425.
      		•
      Scheda tecnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision29-February-2008 JSW
      Synonyms(R,S)-α-Cyano-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
      DescriptionType II pyrethroid insecticide. Potent inhibitor of calcineurin (protein phosphatase 2B, IC50 = 40 pM). May also have varied effects on ion channels.
      FormOil
      CAS number52315-07-8
      RTECSGZ1250000
      Chemical formulaC₂₂H₁₉Cl₂NO₃
      Structure formulaStructure formula
      Purity≥95% by HPLC
      SolubilityDMSO (15 mg/ml) or Ethanol (5 mg/ml)
      Storage +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Toxic
      Merck USA index14, 2767
      ReferencesRichter, A., et al. 1995. Biochem. Pharmacol. 49, 367.
      Wang, J.H., and Stelzer, A. 1994. NeuroReport 5, 2377.
      Enan, E., and Matsumura, F. 1992. Biochem. Pharmacol. 43, 1777.
      Narahasi, T. 1992. Trends Pharmacol. Sci. 13, 236.
      Citation
    • Mike T. Lin, et al. (2005) Ca2+-activated K+ channel-associated phosphatase and kinase activities during development. American Journal of Physiology Heart and Circulatory Physiology 289, H414-H425.
      		•